Evidence map›Paper›PMID 29467287›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2018

Revealing nascent proteomics in signaling pathways and cell differentiation.

Craig M Forester, Qian Zhao, Nancy J Phillips, Anatoly Urisman, Robert J Chalkley, Juan A Oses-Prieto, Li Zhang, Davide Ruggero, Alma L Burlingame

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 70 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. A Dimeric Rocaglate Promotes Multivalent eIF4A-RNA Assembly.bioRxiv : the preprint server for biology · 2026
    Article
  5. Ribosome Molecular Aging Shapes Translation Dynamics.bioRxiv : the preprint server for biology · 2026
    Article
  6. Article
  7. Proteogenomics Reveals Microproteins in Activated T Cells.Molecular & cellular proteomics : MCP · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Craig M ForesterDivision of Pediatric Allergy, Immunology & Bone Marrow Transplantation, University of California, San Francisco, CA 94158.
Qian ZhaoDepartment of Pharmaceutical Chemistry, University of California, San Francisco, CA 94158.
Nancy J PhillipsDepartment of Pharmaceutical Chemistry, University of California, San Francisco, CA 94158.
Anatoly UrismanDepartment of Pathology, University of California, San Francisco, CA 94143.
Robert J ChalkleyDepartment of Pharmaceutical Chemistry, University of California, San Francisco, CA 94158.
Juan A Oses-PrietoDepartment of Pharmaceutical Chemistry, University of California, San Francisco, CA 94158.
Li ZhangHelen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA 94158.
Davide RuggeroHelen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA 94158; Davide.Ruggero@ucsf.edu alb@cgl.ucsf.edu.
Alma L BurlingameHelen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA 94158; Davide.Ruggero@ucsf.edu alb@cgl.ucsf.edu.
University of California, San Francisco · USUCSF Helen Diller Family Comprehensive Cancer Center · USHong Kong Polytechnic University · HK

Funding

Bio-Organic Biomedical Mass Spectromy ResourceP41GM103481 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BURLINGAME, ALMA L · 2012 to 2015
$6.4M
Research Training in Childhood CancerT32CA128583 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Eric Alejandro Sweet-Cordero · 2007 to 2026
$6.0M
The role of deregulated protein synthesis control in Myc-induced tumorigenesisR01CA140456 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI RUGGERO, DAVIDE · 2009 to 2019
$3.3M
Pharmcogenomic dissection of mTOR translational targets in prostate cancerR01CA154916 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI RUGGERO, DAVIDE · 2011 to 2018
$2.8M
Child Health Career Development Program at UCSFK12HD072222 · NICHD · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FERRIERO, DONNA M. · 2013 to 2017
$2.0M
elF4E-Dependent Translation Control in the Oncogenic Stress Response and CancerR01CA184624 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI RUGGERO, DAVIDE · 2014 to 2018
$1.9M
Purchase of Q-Exactive Mass SpectrometerS10OD016229 · OD · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BURLINGAME, ALMA L · 2013 to 2013
$507k
Howard Hughes Medical InstituteNCI NIH HHS R01 CA140456NCI NIH HHS R01 CA154916NCI NIH HHS R01 CA184624NCI NIH HHS T32 CA128583NICHD NIH HHS K12 HD072222NIGMS NIH HHS P41 GM103481NIH HHS S10 OD016229
6 · The paper itself

Abstract

Regulation of gene expression at the level of protein synthesis is a crucial element in driving how the genetic landscape is expressed. However, we are still limited in technologies that can quantitatively capture the immediate proteomic changes that allow cells to respond to specific stimuli. Here, we present a method to capture and identify nascent proteomes in situ across different cell types without disturbing normal growth conditions, using O-propargyl-puromycin (OPP). Cell-permeable OPP rapidly labels nascent elongating polypeptides, which are subsequently conjugated to biotin-azide, using click chemistry, and captured with streptavidin beads, followed by digestion and analysis, using liquid chromatography-tandem mass spectrometry. Our technique of OPP-mediated identification (OPP-ID) allows detection of widespread proteomic changes within a short 2-hour pulse of OPP. We illustrate our technique by recapitulating alterations of proteomic networks induced by a potent mammalian target of rapamycin inhibitor, MLN128. In addition, by employing OPP-ID, we identify more than 2,100 proteins and uncover distinct protein networks underlying early erythroid progenitor and differentiation states not amenable to alternative approaches such as amino acid analog labeling. We present OPP-ID as a method to quantitatively identify nascent proteomes across an array of biological contexts while preserving the subtleties directing signaling in the native cellular environment.

Indexed as

Cell DifferentiationChromatography, LiquidDrug DiscoveryHumansK562 CellsProtein BiosynthesisProteomeProteomicsPuromycinSignal TransductionTandem Mass SpectrometryTOR Serine-Threonine KinasesO-propargyl-puromycinProteomePuromycinTOR Serine-Threonine KinaseserythropoiesismTORproteomicspuromycintranslation

Identifiers

PMID29467287
PMCPMC5877968
OpenAlexW2792476997

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.